Inoperable Cerebral Alveolar Echinococcosis Controlled With High Dosages of Albendazole Adjusted With Monitoring of Blood Levels

Authors

  • Sabine Stauga MD,

    Corresponding author
    1. Section Tropical Medicine, Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
      Sabine Stauga, MD, Section Tropical Medicine, Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Bernhard-Nocht-Strasse 74, D-20359 Hamburg, Germany. E-mail: stauga@bni-hamburg.de
    Search for more papers by this author
  • Stefan Schmiedel MD

    1. Section Tropical Medicine, Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Search for more papers by this author

Sabine Stauga, MD, Section Tropical Medicine, Department of Internal Medicine I, University Medical Center Hamburg-Eppendorf, Bernhard-Nocht-Strasse 74, D-20359 Hamburg, Germany. E-mail: stauga@bni-hamburg.de

Abstract

Cerebral alveolar echinococcosis (AE) is a rare and difficult-to-treat zoonosis caused by Echinococcus multilocularis. A 29-year-old immigrant from Siberia with a past history of hepatic AE, presented with acute onset of grand mal seizures, weakness of the left leg, and cephalgia. Magnetic resonance imaging of the brain revealed inoperable right-sided infiltrative lesions, suggesting cerebral AE. Despite anthelmintic treatment only slow improvement occurred.

Ancillary